Загрузка...
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
OBJECTIVE: Immunological studies have demonstrated a plethora of beneficial effects of dimethyl fumarate (DMF) on various cell types. However, the cellular and molecular targets are incompletely understood and response markers are scarce. Here, we focus on the relation between nuclear factor (erythr...
Сохранить в:
| Опубликовано в: : | Ann Clin Transl Neurol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989754/ https://ncbi.nlm.nih.gov/pubmed/29928650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.553 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|